Stay updated on Pembrolizumab & Carboplatin in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Carboplatin in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Carboplatin in Ovarian Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    No longer looking for participants; new sections added for How to Read a Study Record, Common Questions, and How to Join a Study. Intervention/Treatment labeling was updated and the revision note changed to v3.6.0 from v3.5.5.
    Difference
    0.4%
    Check dated 2026-06-15T05:48:22.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.5.5, replacing Revision: v3.5.4, signaling a new version of the page without altering the study content.
    Difference
    0.1%
    Check dated 2026-06-08T03:51:03.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    23 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.5.3 to v3.5.4, indicating a minor update to the page's metadata. No other content changes are indicated.
    Difference
    0.1%
    Check dated 2026-05-17T09:07:46.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    This update changes the displayed site revision from v3.5.2 to v3.5.3 for the study details page, reflecting a platform/version release rather than any modification to the trial’s content.
    Difference
    0.1%
    Check dated 2026-04-25T18:36:00.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    Added revision: v3.5.2; removed revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-18T13:26:42.000Z thumbnail image
  8. Check
    87 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.3 to v3.5.0 on the page.
    Difference
    0.1%
    Check dated 2026-03-20T19:55:35.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Carboplatin in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Carboplatin in Ovarian Cancer Clinical Trial page.